ArticlePediatric surgery international2026
Genetic insights into pediatric congenital pulmonary airway malformations: a 13-year single-center experience.
Article in Pediatric surgery international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveWith advancements in antenatal imaging techniques, congenital lung lesions are increasingly being diagnosed prenatally, resulting in a growing population of asymptomatic patients encountered by clinicians. However, the etiopathogenesis of these lesions remains unclear, and their malignant potential is not fully understood. In this study, we aimed to investigate the genetic alterations in congenital pulmonary airway malformations (CPAM) and assess their potential for malignant transformation.
methodsThis study included patients under 18 years of age who underwent surgery for congenital pulmonary airway malformation at our institution between 2010 and 2023. Demographic and clinical characteristics were retrospectively analyzed. Lung resection specimens of patients diagnosed with CPAM were re-evaluated, and tissue sections were obtained. For patients operated before 2018, real-time PCR was performed using paraffin-embedded tissue blocks, while targeted next-generation sequencing was employed for cases after 2018 to detect variants in the KRAS gene. The collected data were analyzed using SPSS version 22.0.
resultsAmong 35 patients operated for CPAM, variants in the KRAS gene were detected in 8 patients (22.8%). The majority of cases with variants were diagnosed with type 1 CPAM (p < 0.05). The mean age at surgery was significantly lower in KRAS-positive patients (3.75 ± 2.66 months) compared with KRAS-negative patients (29.89 ± 53.68 months; p < 0.05). No evidence of malignant transformation was observed in any case.
conclusionsKRAS variants can be detected in a subset of pediatric CPAM cases, particularly in type 1 CPAM lesions. KRAS-positive patients underwent surgery at a significantly younger age, likely due to lesion characteristics and antenatal diagnosis. Although no malignant transformation was observed in our series, the presence of KRAS variants indicates a potential molecular predisposition to malignancy. Combining routine histopathological evaluation with targeted molecular analysis can improve risk stratification and guide clinical management. Larger prospective studies are needed to clarify the prognostic and therapeutic implications of KRAS positivity in CPAM.
Indexed as
Identifiers
42867536What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.